⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 29, 2024European RadiologyOpen Access

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI

Ran Yan Wakana Murakami Shabnam Mortazavi Tiffany Yu Fang‐I Chu Stephanie Lee‐Felker Kyunghyun Sung

View Full Paper

Ask AI

Bookmark

Share

Abstract

To compare the quantitative background parenchymal enhancement (BPE) in women with different lifetime risks and BRCA mutation status of breast cancer using screening MRI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yan et al. (2024) studied this question.

synapsesocial.com/papers/68e6d05eb6db64358764e2d3 https://doi.org/10.1007/s00330-024-10758-9

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Automated assessment of background parenchymal enhancement on breast MRI: Impact on breast cancer risk in a matched cohort study2025
2Longitudinal Association of Quantitative Background Parenchymal Enhancement with Breast Cancer Risk Among Women with BRCA1/2 Pathogenic VariantsCohort Study · 2026
3Abstract PO4-08-07: Background parenchymal enhancement (BPE) on breast magnetic resonance imaging as a biomarker of breast cancer risk among BRCA1/2 carriers2024
4Abstract PO5-07-07: The biological basis of breast MRI background parenchymal enhancement in women with high breast cancer risk2024 · 1 citations
5Automated calculation of background parenchymal enhancement as a biomarker of treatment responses and recurrence-free survival in breast cancer2025